SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-118054
Filing Date
2024-04-26
Accepted
2024-04-26 16:11:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d787703ddefa14a.htm DEFA14A 14602
2 GRAPHIC g787703dsp002a.jpg GRAPHIC 3771
3 GRAPHIC g787703page002.jpg GRAPHIC 245475
  Complete submission text file 0001193125-24-118054.txt   358132
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-51531 | Film No.: 24883790
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)